From Seattle Business Magazine: Pattern Computer is on the precipice of discovering new treatments for cancer and other diseases. In less than three years, Pattern Computer Inc. (PCI) has discovered a pair of two-drug candidates for triple-negative breast cancer, the [...]
From Icon Outlook Magazine: Ever since the day computing devices started becoming the mainstream of businesses, data has been the backbone of their operations. In fact, this data has a pattern, that acts as the key concept of every [...]
REDMOND, WA, August 29, 2022 -- Pattern Computer®, Inc. (PCI) is pleased to announce the advancement of three additional combination therapy candidates against High-grade Serous Ovarian cancer beyond the first stage of in vitro studies. In all three cases, the [...]
REDMOND, WA, August 22, 2022 -- Pattern Computer®, Inc. (PCI) is pleased to announce it is partnering with a world leader in the Oil and Gas services industry, adding a new sector to PCI's strong base in other industries. The [...]
From GeekWire: "Pattern Computer takes a unique approach to COVID-19 testing. The company analyzes patterns of light that pass through and are absorbed by spit. The test takes only two drops of saliva and reads off a result from the [...]
REDMOND, WA, August 15, 2022 -- Pattern Computer®, Inc. (PCI) and researchers led by a team from University of Washington have, for the first time, demonstrated that the development of subepithelial Infiltrates (SEI) due to conjunctivitis infection can be accurately [...]
REDMOND, WA, July 7, 2022 -- Pattern Computer®, Inc. (PCI) is pleased to announce placement on the list of the 100 best places to work in Washington State, for Puget Sound Business Journal's annual competition. The top 100 workplaces are [...]
REDMOND, WA, June 29, 2022 -- Pattern Computer Inc. (PCI) is pleased to announce that Ken Goldman and Jan Eric Bolt, Esq. have been elected to the newly expanded Board of Directors for Pattern Computer. Ken Goldman joined Pattern [...]
REDMOND, WA, May 24, 2022 -- Pattern Computer®, Inc. (PCI) is pleased to announce the advancement of our potential combination therapy candidates against High-grade Serous Ovarian cancer beyond the first stage of in vitro studies. In both cases, the [...]
REDMOND, WA, APRIL 18, 2022 -- Pattern Computer®, Inc. (PCI) is thrilled to announce that our combination drug candidates targeting High-grade Serous Ovarian Cancer (HGSOC) have moved into a preclinical in vitro study. The goal is to evaluate the effectiveness [...]